Roberto Ovilla

436 total citations
9 papers, 36 citations indexed

About

Roberto Ovilla is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Roberto Ovilla has authored 9 papers receiving a total of 36 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Hematology, 2 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in Roberto Ovilla's work include Hematopoietic Stem Cell Transplantation (3 papers), Acute Myeloid Leukemia Research (2 papers) and Multiple Myeloma Research and Treatments (2 papers). Roberto Ovilla is often cited by papers focused on Hematopoietic Stem Cell Transplantation (3 papers), Acute Myeloid Leukemia Research (2 papers) and Multiple Myeloma Research and Treatments (2 papers). Roberto Ovilla collaborates with scholars based in Mexico, Brazil and Belgium. Roberto Ovilla's co-authors include Asher Chanan‐Khan, Clara Gorodezky, Piruntha Thiyagarajah, Victor H. Salinas, Vânia Hungria, Noemi Horvath, Jordan M. Schecter, Hang Quach, Pieter Sonneveld and Tineke Casneuf and has published in prestigious journals such as Blood, Autoimmunity Reviews and Blood Advances.

In The Last Decade

Roberto Ovilla

7 papers receiving 35 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Roberto Ovilla Mexico	4	23	15	13	12	6	9	36
Tony Andreas Müller Germany	4	29 1.3×	26 1.7×	16 1.2×	13 1.1×	13 2.2×	7	64
Cody Coblentz United States	2	25 1.1×	22 1.5×	14 1.1×	13 1.1×	12 2.0×	5	52
Valentine Richez France	3	31 1.3×	20 1.3×	5 0.4×	12 1.0×	4 0.7×	8	38
Fabrizio Ciambelli Italy	4	31 1.3×	25 1.7×	10 0.8×	12 1.0×	5 0.8×	8	59
Josip Batinić Croatia	5	36 1.6×	26 1.7×	10 0.8×	7 0.6×	4 0.7×	13	52
Oana Stanca Romania	4	35 1.5×	20 1.3×	17 1.3×	9 0.8×	3 0.5×	9	51
Marek Milewski Poland	3	33 1.4×	50 3.3×	7 0.5×	6 0.5×	5 0.8×	5	69
Marie Odile Petillon France	4	29 1.3×	21 1.4×	9 0.7×	13 1.1×	5 0.8×	4	37
Marianne Huben United States	6	23 1.0×	18 1.2×	15 1.2×	29 2.4×	3 0.5×	11	57
Sumithra Vasu United States	5	42 1.8×	19 1.3×	7 0.5×	10 0.8×	8 1.3×	9	49

Countries citing papers authored by Roberto Ovilla

Since Specialization

Citations

This map shows the geographic impact of Roberto Ovilla's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Ovilla with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Ovilla more than expected).

Fields of papers citing papers by Roberto Ovilla

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Roberto Ovilla. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Ovilla. The network helps show where Roberto Ovilla may publish in the future.

Co-authorship network of co-authors of Roberto Ovilla

This figure shows the co-authorship network connecting the top 25 collaborators of Roberto Ovilla. A scholar is included among the top collaborators of Roberto Ovilla based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Roberto Ovilla. Roberto Ovilla is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Iastrebner, Marcelo, et al.. (2022). Venetoclax and Azacytidine Therapy in High-Risk Myelodysplastic Syndromes: A Retrospective Evaluation of a Real-World Experience. Latin-American MDS Group - Glam. Blood. 140(Supplement 1). 12329–12330.

Grille, Sofía, et al.. (2018). Myelodysplastic syndromes in Latin America: state of the art. Blood Advances. 2(Supplement_1). 60–62. 4 indexed citations

Lentzsch, Suzanne, Hang Quach, Asher Chanan‐Khan, et al.. (2017). Daratumumab, Bortezomib, and Dexamethasone Versus Bortezomib and Dexamethasone for Relapsed/Refractory Multiple Myeloma (RRMM) Patients: An Update of Overall Survival in Castor. Blood. 130. 1852–1852. 7 indexed citations

Chanan‐Khan, Asher, Suzanne Lentzsch, Hang Quach, et al.. (2016). Daratumumab, Bortezomib and Dexamethasone Versus Bortezomib and Dexamethasone Alone for Relapsed or Refractory Multiple Myeloma Based on Prior Treatment Exposure: Updated Efficacy Analysis of Castor. Blood. 128(22). 3313–3313. 7 indexed citations

Pavlovsky, Miguel Arturo, et al.. (2016). Results from a Hemato-Oncology Latin America Observational Registry (HOLA) Providing Real World Outcomes for the Treatment of Patients with NHL. Blood. 128(22). 5327–5327. 3 indexed citations

Ovilla, Roberto, et al.. (2014). Reduction in the Incidence and Severity of Graft Versus Host Disease in HLA-Matched and Haploidentical Bone Marrow Transplantation Using Posttrasplant Cyclophosphamide. Experience of Two Latino-American Institutions. Blood. 124(21). 5880–5880.

Vargas, Pablo Agustín, et al.. (2012). Compassionate Use Program (CUP) with Ruxolitinib in Mexican Patients with Primary Myelofibrosis (PMF), Post – Polycythemia, Vera Myelofibrosis (PPV – MF), and Post–Essential Thrombocythemia Myelofibrosis (PET – MF). Blood. 120(21). 5067–5067. 1 indexed citations

Ovilla, Roberto. (2007). Succesful Treatment with Sirolimus in a Refractory Case of Pure Red Cell Aplasia (PRCA).. Blood. 110(11). 3778–3778. 1 indexed citations

Aláez, C., et al.. (2005). Hematopoietic stem cell transplantation (HSCT): An approach to autoimmunity. Autoimmunity Reviews. 5(3). 167–179. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact